30th Jul 2019 15:35
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. | Details of PDMR/person closely associated with them ('PCA') | ||||
a) | Name | Mrs V A Whyte | |||
b) | Position/status | Company Secretary | |||
c) | Initial notification/ amendment | Initial Notification | |||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | GlaxoSmithKline plc | |||
b) | LEI | 5493000HZTVUYLO1D793 | |||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882 | |||
b) | Nature of the transaction | The exercise of options over 6,910 Ordinary Shares, granted on 22 February 2010 under the GlaxoSmithKline Share Option Plan. | |||
c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
£12.0350 | 6,910 | ||||
d) | Aggregated information
| n/a (single transaction) | |||
Aggregated volume Price | |||||
e) | Date of the transaction | 2019-07-29 | |||
f) | Place of the transaction
| n/a | |||
1. | Details of PDMR/person closely associated with them ('PCA') | ||||
a) | Name | Mrs V A Whyte | |||
b) | Position/status | Company Secretary | |||
c) | Initial notification/ amendment | Initial Notification | |||
2. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | GlaxoSmithKline plc | |||
b) | LEI | 5493000HZTVUYLO1D793 | |||
3. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted | ||||
a) | Description of the financial instrument | Ordinary shares of 25 pence each ('Ordinary Shares')
ISIN: GB0009252882 | |||
b) | Nature of the transaction | The sale of 6,910 Ordinary Shares, granted on 22 February 2010 under the GlaxoSmithKline Share Option Plan. | |||
c) | Price(s) and volume(s) | Price(s) | Volume(s) | ||
£17.3318 | 6,910 | ||||
d) | Aggregated information
| n/a (single transaction) | |||
Aggregated volume Price | |||||
e) | Date of the transaction | 2019-07-29 | |||
f) | Place of the transaction
| London Stock Exchange (XLON) | |||
Related Shares:
Glaxosmithkline